DUBLIN--(BUSINESS WIRE)--The "Global Nanobiotechnology Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The Global Nanobiotechnology Market is forecast to grow at a CAGR of 8.51% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend affecting this market is the increasing demand for nanobiotechnology in stem cell therapy. Stem cells have the potential to develop into different cell types during early life and growth and function as internal repair systems.
According to the report, one driver influencing this market is the rising R&D expenditure in pharmaceutical and biotechnology sectors. The increase in research funding helps in combating various emerging rare diseases.
Further, the report states that one challenge affecting this market is the difficulties in developing nanotechnology products for therapeutics. Nanobiotechnology requires detailed characterization and the successful manufacture of complex constructs.
Key Vendors
- Ablynx
- Celgene
- Merck KGaA
- NanoBiotech Pharma
- Thermo Fisher Scientific
Key Topics Covered
1. Executive Summary
2. Scope of the Report
3. Research Methodology
4. Market Landscape
5. Market Sizing
6. Five Forces Analysis
7. Market Segmentation by End-User
8. Customer Landscape
9. Regional Landscape
10. Decision Framework
11. Drivers and Challenges
12. Market Trends
13. Vendor Landscape
14. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/5qljbk/global?w=4
